Determination Of Half-life Research Articles

Half-life determination of 72Ga

Gallium-72 is an important Comprehensive Nuclear-Test-Ban Treaty relevant radionuclide that arouses significant interest. However, the reported half-lives of 72Ga are discrepant. In the current work, three solution samples of different concentrations were prepared and sequentially measured by a high-purity Germanium (HPGe) spectrometer. The count rates as a function of time of the 834.1 keV and 630.0 keV γ-lines were followed for the half-life determination. Through mass normalization, the datasets of three samples are combined and the statistical uncertainties are reduced. Half-life values were derived from datasets of each sample and mass normalization and corresponding complete uncertainty budgets are presented. The final half-life determined for 72Ga is 13.94 (2) h, showing a deviation of 1.12% from the last nuclear data sheets (NDS) recommended value. Comparing with the values of previous publications, the result from this work is smaller than most results and consistent with the latest value which has one large uncertainty. A recommended value of 14.07 (3) h is estimated using the power-moderated mean (PMM) method.

Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer

BackgroundPlatinum resistance is the primary cause of poor survival in ovarian cancer (OC) patients. Targeted therapies and biomarkers of chemoresistance are critical for the treatment of OC patients. Our previous studies identified cell surface CD55, a member of the complement regulatory proteins, drives chemoresistance and maintenance of cancer stem cells (CSCs). CSCs are implicated in tumor recurrence and metastasis in multiple cancers.MethodsProtein localization assays including immunofluorescence and subcellular fractionation were used to identify CD55 at the cell surface and nucleus of cancer cells. Protein half-life determinations were used to compare cell surface and nuclear CD55 stability. CD55 deletion mutants were generated and introduced into cancer cells to identify the nuclear trafficking code, cisplatin sensitivity, and stem cell frequency that were assayed using in vitro and in vivo models. Detection of CD55 binding proteins was analyzed by immunoprecipitation followed by mass spectrometry. Target pathways activated by CD55 were identified by RNA sequencing.ResultsCD55 localizes to the nucleus of a subset of OC specimens, ascites from chemoresistant patients, and enriched in chemoresistant OC cells. We determined that nuclear CD55 is glycosylated and derived from the cell surface pool of CD55. Nuclear localization is driven by a trafficking code containing the serine/threonine (S/T) domain of CD55. Nuclear CD55 is necessary for cisplatin resistance, stemness, and cell proliferation in OC cells. CD55 S/T domain is necessary for nuclear entry and inducing chemoresistance to cisplatin in both in vitro and in vivo models. Deletion of the CD55 S/T domain is sufficient to sensitize chemoresistant OC cells to cisplatin. In the nucleus, CD55 binds and attenuates the epigenetic regulator and tumor suppressor ZMYND8 with a parallel increase in H3K27 trimethylation and members of the Polycomb Repressive Complex 2.ConclusionsFor the first time, we show CD55 localizes to the nucleus in OC and promotes CSC and chemoresistance. Our studies identify a therapeutic mechanism for treating platinum resistant ovarian cancer by blocking CD55 nuclear entry.

Half-life determination of the ground state decay of 167Tm and 168Tm

Precise determination of half-lives of 167Tm and 168Tm are important for their application in nuclear medicine diagnostics, nuclear forensics, and other nuclear data measurements. We produced 167Tm and 168Tm sources using an α-particle beam bombarded 165Ho target and a series purification steps. A series of 173 measurements was performed over a period of 44 days using a high-purity germanium (HPGe) detector to track the count rate change as a function of time by following the 207.8 keV and 531.5 keV γ-lines to determine the radioactive decay half-life of 167Tm. The measurement of half-life of 168Tm ground state has been performed using the same HPGe γ-ray spectrometer to observe γ-lines at 198.3 keV, 816.0 keV, 184.3 keV, 741.4 keV and 914.9 keV. Weighted least-squares fits of exponential decay curves were performed for the dataset of each γ-ray emission, with final determined half-lives of 9.250(15) d and 93.41(12) d for 167Tm and 168Tm, respectively. The uncertainty budgets are presented and discussed in detail. Our result of 167Tm half-life is consistent with the Evaluated Nuclear Structure Data File (ENSDF) recommended half-life of 9.25(2) d. The outcome of 168Tm half-life determination is longer than the ENSDF recommended half-life of 93.1(2) d. Further independent measurements would be ideal to resolve the discrepancy.

Laser spectroscopy of triply charged 229Th isomer for a nuclear clock.

Thorium-229 (229Th) possesses an optical nuclear transition between the ground state (229gTh) and low-lying isomer (229mTh). A nuclear clock based on this nuclear-transition frequency is expected to surpass existing atomic clocks owing to its insusceptibility to surrounding fields1-5. In contrast to other charge states, triply charged 229Th (229Th3+) is the most suitable for highly accurate nuclear clocks because it has closed electronic transitions that enable laser cooling, laser-induced fluorescence detection and state preparation of ions1,6-8. Although laser spectroscopic studies of 229Th3+ in the nuclear ground state have been performed8, properties of 229mTh3+, including its nuclear decay lifetime that is essential to specify the intrinsic linewidth of the nuclear-clock transition, remain unknown. Here we report the trapping of 229mTh3+ continuously supplied by a 233U source and the determination of nuclear decay half-life of the isolated 229mTh3+ to be through nuclear-state-selective laser spectroscopy. Furthermore, by determining the hyperfine constants of 229mTh3+, we reduced the uncertainty of the sensitivity of the 229Th nuclear clock to variations in the fine-structure constant by a factor of four. These results offer key parameters for the 229Th3+ nuclear clock and its applications in the search for new physics.

Theoretical investigation of heavy cluster decay from Z=118 and 120 isotopes: A search for an empirical formula in superheavy region

Various decay modes in superheavy nuclei have been of significant interest among which cluster radioactivity has recently gained sizable attention. The α-decay being a predominant decay mode in the superheavy region, the accurate determination of cluster decay half-lives is also crucial in this region as it has tremendous potential to be explored as one of the major decay channels. The usability of the Royer analytical formula [Nuclear Physics A 683 (2001) 182], which is based on the asymmetric fission model, has been investigated for the cluster and α-decay in superheavy region, by comparing it with several other (semi)empirical/analytical formulas. After fitting the formula on around 100 cluster-decay data and around 423 α-decay data, the refitted Royer formula (RRF) is found to be very robust which is able to estimate the cluster decay and α-decay half-lives with good accuracy. In fact, a comparison of the half-lives of both the decay modes using the same formula points towards a substantial chance of heavy cluster (Kr and Sr) decay from various isotopes of Z=118 and 120. Hence, the formula proposed in this study works fairly well for the estimation of cluster decay half-lives in superheavy regions where most empirical formulas fail to match with the half-lives from the various established theories.

Half-life determination of 215At and 221Ra with high-purity radioactive ion beams

At CERN-ISOLDE, high-purity radioactive ion beams of 219Fr and 221RaF were investigated with α-decay spectroscopy at the CRIS and ASET experiments in the course of three different experimental campaigns. The half-life of 215At, α-decay daughter of 219Fr, is measured to be 36.3(3)[9]μs, and that of 221Ra was determined to be 26.2(1)[6]s, both of which are well in line with the trends in this region of the nuclear landscape but at odds with some of the reported literature.

Analysis of sRNAs and Their mRNA Targets in Sinorhizobium meliloti: Focus on Half-Life Determination.

Regulation of gene expression at the level of RNA and/or by regulatory RNA is an integral part of the regulatory circuits in all living cells. In bacteria, transcription and translation can be coupled, enabling regulation by transcriptional attenuation, a mechanism based on mutually exclusive structures in nascent mRNA. Transcriptional attenuation gives rise to small RNAs that are well suited to act in trans by either base pairing or ligand binding. Examples of 5'-UTR-derived sRNAs in the alpha-proteobacterium Sinorhizobium meliloti are the sRNA rnTrpL of the tryptophan attenuator and SAM-II riboswitch sRNAs. Analyses addressing RNA-based gene regulation often include measurements of steady-state levels and of half-lives of specific sRNAs and mRNAs. Using such measurements, recently we have shown that the tryptophan attenuator responds to translation inhibition by tetracycline and that SAM-II riboswitches stabilize RNA. Here we discuss our experience in using alternative RNA purification methods for analysis of sRNA and mRNA of S. meliloti. Additionally, we show that other translational inhibitors (besides tetracycline) also cause attenuation giving rise to the rnTrpL sRNA. Furthermore, we discuss the importance of considering RNA stability changes under different conditions and describe in detail a robust and fast method for mRNA half-life determination. The latter includes rifampicin treatment, RNA isolation using commercially available columns, and mRNA analysis by reverse transcription followed by quantitative PCR (RT-qPCR). The latter can be performed as a one-step procedure or in a strand-specific manner using the same commercial kit and a spike-in transcript as a reference.

Primary standardization and half-life determination of [formula omitted]Ac at NRC

A solution of 225Ac was standardized by NRC using the triple-to-double coincidence ratio (TDCR) method. The counting efficiencies were calculated assuming a counting efficiency of 100% for alpha decays and those calculated using the MICELLE2 Monte Carlo code for beta decays and was approximately 500% for the NRC TDCR system. The relative uncertainty for the activity concentration was determined to be 0.25%. This agreed with measurements performed using gamma spectroscopy and a predicted calibration factor for the Vinten 671 ionization chamber as calculated using an EGSnrc model, implementing radioactive decay. Finally, the half-life of 225Ac was determined from long-term measurements using ionization chambers and liquid scintillation counting. The NRC measured half-life for 225Ac was found to be 9.914(4) days and is consistent within an expanded uncertainty coverage of k = 2 with the most recent (Kossert et al., 2020; Pommé et al., 2012) measurements of this decay parameter.

A new determination of the 68Ga half-life and evaluation of literature data

Inconsistencies within the 68Ga half-life dataset have been repeatedly identified in nuclear decay data evaluations performed over the past decade. In this paper, a half-life has been determined using ionisation chambers measurements and HPGe gamma-ray spectrometry (T1/2 = 67.783(27) min). The current literature has been reviewed and possible causes of discrepancy have been identified, such as neglected contaminant effects, robustness of analysis, and underestimation of systematic effects. This could lead to a significant improvement of the half-life in future evaluations.

Determination of the elimination half-life of Glyphosate and its main metabolite, AMPA, in chicken plasma

Glyphosate-based herbicides (GBHs) are the most-used herbicides worldwide. Concerns about their toxicity and ecotoxicity have motivated scientists to assess their potential effects on animals, as well as their toxicokinetic parameters in rats and humans. However, to our knowledge, such data have not been produced for avian models. In this study, toxicokinetic parameters for glyphosate and AMPA were calculated after one unique dietary exposure (40 mg of glyphosate equivalent per kg) and one unique intravenous injection of a GBH, in hens and roosters respectively. Non compartmental analysis was used to show the evolution of glyphosate and AMPA plasma concentrations over time. After one unique intravenous injection of a glyphosate-based herbicide, glyphosate and AMPA were quickly eliminated from plasma and were poorly distributed (Vssglyphosate = 0.30 L/kg). Their terminal half-lives are 4.7 h and 8.10 h, respectively. After dietary exposure, glyphosate and AMPA followed a 6 h absorption phase followed by a 42 h elimination phase. They were poorly distributed (Vssglyphosate = 0.00562 L/kg), and their maximum concentrations (Cmax) were 21285 µg/L and 108 µg/L, respectively. Their terminal elimination half-lives were 8.94 h and 6.93 h, respectively. Taken together, this study provides new data on the elimination rate and approximate biological half-life range of glyphosate in birds.

Application of the most frequent value method for ^{39}Ar half-life determination

An evaluation method supported by robust statistical analysis was applied to historical measurements of ^{39}Ar half-life. The method, based on the most frequent value (MFV) approach combined with bootstrap analysis, provides a more robust way to estimate ^{39}Ar half-life, and results in T_{1/2}(MFV) = 268.2^{+3.1}_{-2.9} years with uncertainty corresponding to the 68% confidence level. The uncertainty is a factor of 3 smaller than that of the most precise re-calculated ^{39}Ar half-life measurements by Stoenner et al. and a factor of 2.7 smaller than that of the adopted half-life value in nuclear data sheets. Recently, the specific activity of the beta decay of ^{39}Ar in atmospheric argon was measured in several underground facilities. Applying the MFV method to a specific activity of ^{39}Ar from underground measurements results in SA_{{^{39}text {Ar}}/text {Ar}}(text {MFV}) = 0.966^{+0.010}_{-0.018} , , text {Bq/kg}_{text {atmAr}} with uncertainty corresponding to the 68% confidence level. In this paper the method to determine the half-life of ^{39}Ar using the specific activity of ^{39}Ar in atmospheric argon is also discussed.

Determination of the Terbium-152 half-life from mass-separated samples from CERN-ISOLDE and assessment of the radionuclide purity

Terbium-152 is one of four terbium radioisotopes that together form a potential theranostic toolbox for the personalised treatment of tumours. As 152 Tb decay by positron emission it can be utilised for diagnostics by positron emission tomography. For use in radiopharmaceuticals and for activity measurements by an activity calibrator a high radionuclide purity of the material and an accurate and precise knowledge of the half-life is required. Mass-separation and radiochemical purification provide a production route of high purity 152Tb. In the current work, two mass-separated samples from the CERN-ISOLDE facility have been assayed at the National Physical Laboratory to investigate the radionuclide purity. These samples have been used to perform four measurements of the half-life by three independent techniques: high-purity germanium gamma-ray spectrometry, ionisation chamber measurements and liquid scintillation counting. From the four measurement campaigns a half-life of 17.8784(95) h has been determined. The reported half-life shows a significant difference to the currently evaluated half-life (ζ-score = 3.77), with a relative difference of 2.2 % and an order of magnitude improvement in the precision. This work also shows that under controlled conditions the combination of mass-separation and radiochemical separation can provide high-purity 152Tb.

Activity standardization of 32Si at PTB

Within the scope of the SINCRON project, several 32Si solutions were measured by means of liquid scintillation (LS) counting techniques at PTB to determine the activity concentration. Initial results revealed limited long-term stability of the samples, and a discrepancy between the TDCR method and the CIEMAT/NIST efficiency tracing method was found. In some cases, the sample instability could not be completely avoided but there is evidence that the results of the first measurements which are carried out within a few days after sample preparation can be used for an activity determination, though with increased uncertainty. Various sample compositions were tested, and a systematic study of long-term measurements and further experiments indicates that the sample instability is due to an adsorption-like effect. The discrepancies between the two LS methods were significantly lower when measuring other 32Si solutions. The initially observed discrepancies are likely due to low-energetic radioactive impurities that can be present in some of the 32Si solutions. A spectral analysis supports the thesis that tritium is present in the first solution and even allows a rough quantification of the activity ratio A(3H)/A(32Si/32P). This value allows impurity corrections to be applied, which leads to a noticeable improvement in the agreement between TDCR and CIEMAT/NIST efficiency tracing. Finally, a new LS sample composition with 15 mL Ultima Gold and 1 mL of HCl (0.5 mol/L) was found to yield stable LS samples. The activity determinations presented in this paper represent a fundamental step towards a new 32Si half-life determination in the framework of the SINCHRON project.

Thermal and Acoustic Stabilization Of Volatile Phase-Change Contrast Agents Via Layer-By-Layer Assembly.

Phase-change contrast agents (PCCAs) are perfluorocarbon nanodroplets (NDs) that have been widely studied for ultrasound imaging in vitro, pre-clinical studies, and most recently incorporated a variant of PCCAs, namely a microbubble-conjugated microdroplet emulsion, into the first clinical studies. Their properties also make them attractive candidates for a variety of diagnostic and therapeutic applications including drug-delivery, diagnosis and treatment of cancerous and inflammatory diseases, as well as tumor-growth tracking. However, control over the thermal and acoustic stability of PCCAs both in vivo and in vitro has remained a challenge for expanding the potential utility of these agents in novel clinical applications. As such, our objective was to determine the stabilizing effects of layer-by-layer assemblies and its effect on both thermal and acoustic stability. We utilized layer-by-layer (LBL) assemblies to coat the outer PCCA membrane and characterized layering by measuring zeta potential and particle size. Stability studies were conducted by; 1) incubating the LBL-PCCAs at atmospheric pressure at 37∘C and 45∘C followed by; 2) ultrasound-mediated activation at 7.24 MHz and peak-negative pressures ranging from 0.71 - 5.48 MPa to ascertain nanodroplet activation and resultant microbubble persistence. The thermal and acoustic properties of decafluorobutane gas-condensed nanodroplets (DFB-NDs) layered with 6 and 10 layers of charge-alternating biopolymers, (LBL6NDs and LBL10NDs) respectively, were studied and compared to non-layered DFB-NDs. Half-life determinations were conducted at both 37∘C and 45∘C with acoustic droplet vaporization (ADV) measurements occurring at 23∘C. Successful application of up to 10 layers of alternating positive and negatively charged biopolymers onto the surface membrane of DFB-NDs was demonstrated. Two major claims were substantiated in this study; namely, (1) biopolymeric layering of DFB-NDs imparts a thermal stability up to an extent; and, (2) both LBL6NDs and LBL10NDs did not appear to alter particle acoustic vaporization thresholds, suggesting that the thermal stability of the particle may not necessarily be coupled with particle acoustic vaporization thresholds. Results demonstrate that the layered PCCAs had higher thermal stability, where the half-lifes of the LBLxNDs are significantly increased after incubation at 37∘C and 45∘C. Furthermore, the acoustic vaporization profiles the DFB-NDs, LBL6NDs, and LBL10NDs show that there is no statistically significant difference between the acoustic vaporization energy required to initiate acoustic droplet vaporization.

Measuring the half-life of 215Po by low-level liquid scintillation counting

The half-life of short-lived 215Po was studied in a new experimental setup by means of liquid scintillation counting. The new value of 1.781 (5) ms was obtained by offline data analysis using the delayed coincidence method. Along with the half-life determination, a careful assessment of uncertainties was carried out. The result was compared with data available from the literature.

Liquid scintillation counting: A valuable tool to determine half-lives

In the past two decades, the radionuclide metrology group at PTB has carried out a number of half-life determinations using liquid scintillation counting. The half-lives, which were often determined in collaboration with other institutions, range from a few ten nanoseconds (e.g., 86 keV level of 233Pa) to several billion years (e.g., 87Rb). This review aims to give an overview of the various half-life determination techniques that have been used and to demonstrate the great potential of liquid scintillation counting as an experimental tool for such measurements.

FITEVT: A FORTRAN program for arrival-time analysis of nuclear-decay events

FITEVT is a FORTRAN program designed to analyze recorded arrival times of nuclear-decay events affected by dead-time. The primary goal of the program is precise and accurate determination of half-lives. Its method involves imposition of a known sufficiently long extending dead-time to the recorded event sequence, so that the original dead-time effects are completely obliterated and the remaining live-times of the survived events are known exactly. Upon completion of the analysis, the arrival-time spectrum and the live-time spectrum are predicted and compared to those constructed from the survived events. Program summaryProgram title: FITEVTLicensing provisions: MITCPC Library link to program files:https://doi.org/10.17632/scg6p9jxjk.1Programming language: FORTRAN (using double precision)Nature of problem: Accurate determination of the ideal event rate from the observed event rate in a nuclear decay can be a challenging task due to the inevitable presence of detection system's dead-time, whose nature and extent are typically unknown. Consequently, the results of nuclear half-life measurements may depend on the method used to correct for event losses due to dead-time. Therefore, there is a need for an exact method of data analysis and the means to apply it in order to ensure reproducibility, accuracy and optimized precision of the results.Solution method: FITEVT performs arrival-time analysis of the recorded events, in which a known, sufficiently large extending dead-time is imposed by means of software, so that in the resulting set of survived events the original dead-time effects are completely replaced by the effects of the imposed dead-time. As a result, the dead-time following each survived event and the remaining live-time preceding each surviving event are known exactly. This allows for application of the maximum-likelihood method of estimation, in which the half-lives as well as the other parameters of the ideal-decay-rate function can be accurately determined.Additional comments including restrictions and unusual features: In its original form the program can handle contributions from a constant event rate (i.e., a typical background) plus up to 4 different exponentially-decaying event rates. One of these 4 contributions is allowed to be negative, so that the program can be applied to the general case involving a single two-component decay chain. The employed method of analysis produces accurate results even when the product of the ideal event rate (ρ) and the extending dead-time parameter (τe) is as large as 51.2 [1]. Example used in the present paper involves simulated events having initial rate of 105 s−1, to which extending dead-time of 64 μs is imposed.Data analysis is based on maximum-likelihood principle, in which minimization of the deviance involves calculations in double precision and determination of its derivatives is based on analytical expressions. This is done in order to optimize precision and accuracy of the results as well as the program execution time.With the provided input data and a typical contemporary laptop computer, the program execution typically lasts about 5 minutes. Reducing the imposed dead-time to zero increases the number of survived events approximately by a factor of 6, but the program execution time increases by about a factor of 3.

Half-life determination of 155Tb from mass-separated samples produced at CERN-MEDICIS

Terbium-155 has been identified for its potential for single-photon emission computed tomography (SPECT) in nuclear medicine. For activity measurements, an accurate and precise half-life of this radionuclide is required. However, the currently evaluated half-life of 5.32(6) d with a relative standard uncertainty of 1.1% determines the precision possible. Limited literature for the half-life measurements of this radionuclide is available and all reported investigations are prior to 1970. Further measurements are therefore needed to confirm the accuracy and improve the precision of the half-life for its use in the clinical setting. Two samples produced and mass separated at the CERN-MEDICIS facility have been measured at the National Physical Laboratory by two independent techniques: liquid scintillation counting and high-purity germanium gamma-ray spectrometry. A half-life of 5.2346(36) d has been determined from the weighted mean of the half-lives determined by the two techniques. The half-life reported in this work has shown a relative difference of 1.6% to the currently evaluated half-life and has vastly improved the precision.

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor.

Acute pulmonary embolism (APE) is a debilitating condition with high incidence and mortality rates. APE is widely treated with the serine protease urokinase or urokinase-type plasminogen activator (uPA) that functions by resolving blood clots via catalyzing the conversion of plasminogen to plasmin. Treatment with recombinant uPA has been shown to increase endogenous expression of uPA and its cognate receptor, uPAR; however, the mechanisms for this induction are not known. Using an in vitro hypoxia/reoxygenation model in bronchial epithelial BEAS-2B cells, we show that induction of hypoxia/reoxygenation induces apoptosis and increases secretion of tumor necrosis factor–alpha, brain natriuretic peptide, and fractalkine, which are attenuated when treated with exogenous uPA. Induction of hypoxia/reoxygenation resulted in decreased expression of uPAR on cell surface without any significant changes in its messenger RNA expression, highlighting post-transcriptional regulatory mechanisms. Determination of uPAR protein half-life using cycloheximide showed treatment with uPA significantly increased its half-life (209.6 ± 0.2 min from 48.2 ± 2.3 min). Hypoxia/reoxygenation promoted the degradation of uPAR. Inhibition of proteasome-mediated degradation using MG-132 and lactacystin revealed that uPAR was actively degraded when hypoxia/reoxygenation was induced and that it was reversed when treated with exogenous uPA. Determination of the proteolytic activity of 20S proteasome showed a global increase in ubiquitin–proteasome activation without an increase in proteasome content in cells subjected to hypoxia/reoxygenation. Our results cumulatively reveal that uPAR is actively degraded following hypoxia/reoxygenation, and the degradation was significantly weakened by exogenous uPA treatment. Given the importance of the uPA/uPAR axis in a multitude of pathophysiological contexts, these findings provide important yet undefined mechanistic insights.

Determination of Half-lives of Circulating FSH and LH Glycoforms in Women During GnRH Receptor Blockade.

Both FSH and LH circulate as 2 glycoforms, differing in number of glycans: low-N-glycosylated glycoforms, FSHtri and LHdi, and fully N-glycosylated glycoforms, FSHtetra and LHtri. To determine the half-lives of endogenous circulating gonadotropin glycoforms in women during GnRH receptor blockade. Serum samples were collected in 8 healthy women before and up to 20 hours after administration of the NAL-GLU GnRH antagonist. Three women were in early follicular phase, 2 at mid-cycle phase, and 3 were postmenopausal. The half-life of each glycoform was estimated by monoexponential decay for FSH (n = 8) and LH (n = 5). Data were analyzed using paired t tests. Half-lives in the circulation of low-N-glycosylated glycoforms of both FSH and LH were shorter than those of the fully N-glycosylated glycoforms (mean; range, FSHtri 343; 116-686 minutes vs FSHtetra 757; 436-1038, minutes, P = 0.0003; LHdi 125, 84-198 minutes vs LHtri 164, 107-235 minutes, P = 0.004). The half-lives of low-and fully N-glycosylated forms of LH were shorter than the corresponding half-lives of FSH glycoforms, P = 0.0008. For both FSH and LH, low-N-glycosylated glycoforms disappeared from the circulation faster than the fully N-glycosylated. The half-lives of low and fully N-glycosylated forms of LH were shorter than the corresponding half-lives of FSH. The estimated values for half-life in the circulation of total FSH and total LH will depend on the relative amounts of the 2 glycoforms of each hormone and their individual disappearance rates in circulation.